SUBSCRIBE
SUBSCRIBE

Oded Ben-Joseph

Opinion author

Oded Ben-Joseph, PhD, MBA, is a founder and managing partner at Outcome Capital, a highly specialized life science strategic advisory and investment banking firm. He is passionate about helping cutting-edge life sciences companies enhance their clinical and strategic value and chart a path to successful liquidity. He has held numerous entrepreneurial and operational roles, including co-founder and director of ELIOS Vision (now Bauch and Lomb), CEO of XCell Medical, Ester Neurosciences and Caliber Therapeutics, and executive in residence at Oxford Bioscience Partners. His academic appointments include assistant professor at the University of Michigan (Radiology and Neuroscience), visiting associate professor at Tokushima University and visiting scientist at Pfizer. He has published numerous scientific and industry papers. Ben-Joseph received a B.Sc. from Imperial College London and a Ph.D. from the University of Cambridge. He completed his postdoctoral training at the University of Michigan and received an MBA from the University of Bradford.

Boss gets attention from employee colleagues in serious meetings in the late evening of the working hour with sundown dusk sky. Business people work hard and brainstorm in the office conference room
Opinion
Extending Scientific Rigor From Bench to Boardroom
Many scientists-turned-CEOs paradoxically abandon scientific principles when it comes to commercializing their innovations. But applying the scientific method to business decisions can help life science entrepreneurs avoid common pitfalls, attract investment and ultimately bring transformative technologies to market.
February 19, 2026
 · 
6 min read
 · 
Oded Ben-Joseph